Sort   by:  
 Page size 
UnknownUbiquitylation of the initiator caspase DREDD is required for innate immune signalling.
Not available
S-EPMC3380211 | biostudies-literature
UnknownSUMO-mediated regulation of NLRP3 modulates inflammasome activity.
Not available
S-EPMC6070540 | biostudies-literature
UnknownSPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer.
Not available
S-EPMC12675285 | biostudies-literature
UnknownSignal Integration by the IκB Protein Pickle Shapes Drosophila Innate Host Defense.
Not available
S-EPMC5026699 | biostudies-literature
UnknownEndocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.
Not available
S-EPMC10543960 | biostudies-literature
UnknownPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Not available
S-EPMC5200636 | biostudies-literature
UnknownHNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.
Not available
S-EPMC9511995 | biostudies-literature
UnknownInterlaboratory Study for Characterizing Monoclonal Antibodies by Top-Down and Middle-Down Mass Spectrometry.
Not available
S-EPMC7539639 | biostudies-literature
UnknownApplication of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
Not available
S-EPMC7217941 | biostudies-literature
UnknownAdjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186 | biostudies-literature
Sort   by:  
 Page size